General Information


DRACP ID  DRACP03588

Peptide Name  

Sequence  kQrWlWlW

Sequence Length  8

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  Mix



Physicochemical Information


Formula  C38H32N8O2

Absent amino acids  ACDEFGHIKLMNPRSTVY

Common amino acids  W

Mass  75776

Pl  6.11

Basic residues  0

Acidic residues  0

Hydrophobic residues  3

Net charge  0

Boman Index  145

Hydrophobicity  -77.5

Aliphatic Index  0

Half Life 
  /

Extinction Coefficient cystines  16500

Absorbance 280nm  2357.14

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 11473322

Title  Antibacterial agents based on the cyclic D,L-alpha-peptide architecture

Doi Not available

Year  2001

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  8061

DRACP is developed by Dr.Zheng's team.